This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Mednax (MD) Invests in Brave Care to Boost Pediatric Business
by Zacks Equity Research
Mednax (MD) and Brave Care form a relationship to provide enhanced pediatric care and pursue its pipeline of pediatric clinics' plan.
UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.
Teladoc (TDOC) Broadens Accessibility of Primary Care Model
by Zacks Equity Research
Teladoc Health (TDOC) intends to offer enhanced primary care to its members through Primary360, whose reach has now extended to commercial health plans and employers.
5 Cheap Dividend Growth Stocks Worth Your Attention
by Sweta Killa
These dividend growth stocks like Penske Automotive (PAG), HCA Healthcare (HCA), Applied Materials (AMAT), Boyd Gaming (BYD) and General Dynamics (GD) are worth your attention given the stock market volatility.
Ensign Group (ENSG) Acquires to Expand in Texas & Idaho
by Zacks Equity Research
Ensign Group (ENSG) establishes dominance in the Texas and Idaho markets with further buyouts.
UnitedHealth (UNH) Unit to Offer Better Pharmacy Care in Arizona
by Zacks Equity Research
Genoa, which comes under UnitedHealth Group's (UNH) subsidiary Optum, opens a pharmacy in one of Arizona's clinics for offering enhanced pharmacy care for behavioral health patients.
HCA Healthcare (HCA) Up 109.5% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) cost-curbing measures, strategic initiatives and a solid guidance are likely to bump up its shares.
Teladoc (TDOC) to Offer Remote Solutions for Canada Patients
by Zacks Equity Research
Teladoc Health (TDOC) has been selected by Infoway for providing remote patient monitoring solutions throughout Canada, thereby resulting in better health conditions.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
HCA (HCA) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why You Should Retain MEDNAX (MD) in Your Portfolio
by Zacks Equity Research
Riding high on its revenue stream and strategic measures, MEDNAX (MD) holds potential to reap benefits for investors.
Here's Why You Should Buy Acadia Healthcare (ACHC) Stock Now
by Zacks Equity Research
Acadia Healthcare (ACHC) continues to gain from top-line growth, solid demand for behavioral health services, several growth-related initiatives and reducing debt levels.
HCA Healthcare (HCA) to Acquire Facilities in Utah From Steward
by Zacks Equity Research
HCA Healthcare (HCA) to buy five Utah hospitals from Steward to expand its dominance in the region, and provide cost-effective and enhanced healthcare to patients.
Acadia Healthcare (ACHC) Starts Building New Behavioral Facility
by Zacks Equity Research
Acadia Healthcare (ACHC) opens a new behavioral facility to tap the growing market of mental illness.
How to Find Strong Buy Medical Stocks Using the Zacks Rank
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
3 Hospital Stocks That Outperformed the S&P Index Year to Date
by Srijita Guha
High patient volumes, mergers and buyouts and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH outperform the S&P Index.
Community Health (CYH) Up 136.3% in a Year: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) cost-cutting measures and strategic initiatives are likely to drive its shares higher.
LHC Group (LHCG) to Boost Nationwide Presence With New Buyout
by Zacks Equity Research
LHC Group's (LHCG) deal win enables the company to acquire home health, hospice and therapy assets in 22 states.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Backed by its strategic measures, solid segmental contributions and a strong solvency level, Universal Health (UHS) holds potential to reap benefits for investors.
Tenet Healthcare (THC) Expands Its Relationship With Cigna
by Zacks Equity Research
Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.
Cigna (CI) Extends Tie-Up to Offer Better Care in Connecticut
by Zacks Equity Research
Cigna (CI) extends relationship with Hartford HealthCare to jointly offer enhanced healthcare services and thus, better health outcomes in Connecticut.
Acadia Healthcare (ACHC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.